|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cancer-Related Problem/Condition | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Neutropenia | |||||
| 3 | More general conditions related to this trial | ||||
| Agranulocytosis | |||||
| Hematologic Diseases | |||||
| Leukocyte Disorders | |||||
| Leukopenia | |||||
| 4 | Interventions listed in this trial | ||||
| filgrastim | |||||
| 5 | Sponsors listed in this trial | ||||
| Children's Oncology Group | |||||
| National Cancer Institute (NCI) | |||||